We’re proud to share that Dr. Jorge Chaves, Chief Medical Officer at P1 Pratia Oncology and Director of the Phase I Clinical Research Program at Northwest Medical Specialties, recently joined a panel of oncology experts for the Xtalks webinar, “ASCO 2026: Turn Oncology Data into Smarter Trial Strategy.” Bringing his perspective as a principal investigator with over 15 years of experience in phase I and first-in-human oncology trials, Dr. Chaves helped unpack how this year’s ASCO highlights, from targeting previously “undruggable” cancer biology to advances in personalized cancer vaccines and biomarker-driven treatment, are reshaping clinical trial design, patient selection and site-level execution. Alongside fellow panelists representing the CRO/sponsor and clinical research site perspectives, Dr. Chaves offered a grounded, practice-based view on what it truly takes to translate cutting-edge oncology science into trials that deliver real benefit for patients. The full session is now available on-demand.